Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf7925a5cca66f1625e1fa44f5b5b400 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-502 |
filingDate |
2007-10-15^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a5fd7759a65bb08e2ddaf6e9ccdad4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c98c2f370601d8e2b4cc2d1b56bfd0dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d9170faa8a9fe8c6f2dcf675ea3b833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9a847d79915bc39feafe13a99350f29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff9b0abd769917605c527c7f1f58b4a0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c16dc2d6377c8c52b731611373f179e8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45c666afcb2adb4c3c68f2bbd1c1f885 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3f3c05320fdeeceac5dd68af85d5ebf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9386a037b4853611be31b401d0d39005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_37913382ad170a9fab30e6d3b16549e6 |
publicationDate |
2008-04-24^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2664275-A1 |
titleOfInvention |
Crystalline form phthalazinone derivative for use in cancer treatment |
abstract |
4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one as crystalline Form A. |
priorityDate |
2006-10-17^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |